Upcoming Webinars

In this webinar, the featured speaker will discuss the rapid single B-cell cloning workflow that ChemPartner is using to discover rabbit antibodies. Attendees will get an understanding of the Beacon system, the scientific background of the workflow, as well as an overview of the characteristics of the antibodies discovered in this case study.

Dive into this essential session with Microsoft, Theta Lake, and Wells Fargo, as we explore the expansive benefits of Microsoft 365 and the Compliance capabilities required to leverage Unified Communications and Collaboration across robust platforms like Teams, Viva, and SharePoint, among others. This webinar will shed light on the power of M365 capabilities and how the Microsoft ecosystem of certified compliance partners Like Theta Lake empower FS organizations to address regulatory and organizational communication compliance needs. By maximizing Microsoft 365 UC capabilities, financial institutions can significantly boost productivity and ROI while improving compliance, even in a heavily regulated landscape. You’ll hear from Microsoft leadership about M365 trends and capabilities in financial services, the perspective of a major global bank on how they utilize M365, as well as how a specialized ISV partner like Theta Lake uses Microsoft APIs to address the requirements of highly regulated organizations. Discover how to enable more productivity-boosting features across diverse modalities and collaboration applications, all while maintaining the highest standards of corporate and regulatory compliance. Through real-world insights, grasp how leveraging the Microsoft ecosystem substantially elevates communication and collaboration, driving forward a culture of compliance and operational excellence. We're excited to present a stellar panel for this webinar, hosted by Rob Scott, Publisher at UC Today. Joining are Devin Redmond, CEO & Co-founder of Theta Lake, Kirk Koenigsbauer, COO & Corporate VP, Experiences + Devices Group at Microsoft, and Leo Brito, EVP Workforce Experience and Productivity Solutions at Wells Fargo. Their diverse expertise promises insightful discussions on navigating regulatory compliance with Microsoft 365. Don’t miss the chance to engage with industry leaders on real-world solutions for financial institutions.

In this groundbreaking webinar, discover the latest in retina therapy programs and clinical research to enhance success in ophthalmic trials with insights from industry experts. With over 250 individual therapies in development to address these challenging-to-treat conditions including inherited retina diseases, diabetic retinopathy and macular degeneration, the innovation within this space is likely unsurpassed by any other. Excitingly, many of these include novel mechanisms of action or gene therapies that show potential for different therapeutic impacts from current therapies on the market, such as treating conditions where there are no therapies with approved indications or targeting earlier-stage disease interventions.

Date & Time: Dec 9, 2023 10:00 PM in Universal Time (UTC)

Late October to January each year is laden with Religious Festivals and Celebrations. From Halloween to Epiphany and beyond to Easter, many people celebrate but do not know either the Natural origins or deeper symbolic meaning behind them. This session delivered by Paul Obinna explores the origin of these "Winter Festivals" and like the presenter, allow participants to better appreciate their positive aspects beyond the commercialism. THIS EVENT IS NOT TO BE MISSED!!

What: Photographing Flowers for Transparency is a benefit webinar with Harold Davis. Proceeds will be donated to Doctors without Borders. Tuition (not tax deductible) is $29.95. Advance registration via Zoom is required. When: Saturday December 9, 2023, at 11am PT Details: In this presentation, Harold Davis shows his stunning floral imagery and explains in detail his process for light box photography. Botanical composition, exposure, and post-production are explained. Harold says: Light box photography is a joy in and of itself, and is a great form of photography to practice at home with relatively minimal investment in equipment. Techniques that can be learned from light box photography cut across myriad aspects of photography, and will enrich all aspects of your photographic practice. The presentation will include an actual example of post-production processing using Harold's techniques for which he was awarded the 2022 Progress Award by the Photographic Society of America. There will be ample time for Q&A. Phyllis Davis will moderate this webinar.

Our audience will be guided into the critical intersection of legal and regulatory patterns in Artificial Intelligence (AI), diversity, and inclusion at the global level, emphasizing the following key points:bias and discrimination in AI: examples and impacts of biases in AI systems;existing regulatory frameworks and international standards - a critical assessment from International Law;the quest for the centrality of diversity and inclusion in AI regulation and the enforcement of human rights on a global scale;the strategies to encourage diversity and inclusionary practices in AI regulatory patterns;specific cases and future directions.

Join us for a cutting-edge webinar delving into innovative clinical approaches and endpoints for new glaucoma treatments. Today, intraocular pressure (IOP) lowering therapies are currently the only proven neuroprotective therapies for glaucoma. While IOP therapies and devices are highly prevalent in use, unfortunately even with these treatments up to one in four patients still experience blindness in at least one eye. With disease progression still often significant despite the application of these therapies, clearly, this is an area of opportunity for new therapeutic entries. As companies explore new therapies to provide neuroprotection (preserving neuronal integrity) or even neuroenhancement (improving neuronal function), finding the right clinical approaches and endpoints to prove efficacy is of utmost importance. This webinar, featuring leading glaucoma expert and Ora Chief Medical Officer, Dr. Gustavo De Moraes, highlights ground-breaking designs and endpoints for new glaucoma therapies that help better measure therapeutic impact and even demonstrate IOP-independent neuroprotection. Hear an overview of the latest research in this field, understand considerations for programs including currently stated FDA opinions, and dive deeply into recent studies that show the viability of these novel endpoints to demonstrate efficacy for new glaucoma potential therapies. Ora Inc. is the only ophthalmic clinical trials company with a research and development (R&D) department focused on the evolution of clinical trials. As one of the top glaucoma experts in the world, Dr. De Moraes leads the Ora R&D team in exploring and developing new endpoints. He is excited to share with attendees the latest research shaping the future of glaucoma clinical trials, and to provide considerations for their therapeutic program to optimally capture the efficiency benefits for these challenging patients.

Workforce turnover and retention is a perennial concern for child welfare agency management with implications for service outcomes for families and children...

Contamination is an everyday challenge in cell culture labs. Undetected or ignored contamination endangers the reliability and reproducibility of experimental data. In this webinar, attendees will learn how to recognize and identify different types of contaminants. The featured speaker will give practical tips for preventing contamination by incorporating standard procedures into daily culture practices.